Research Progression of Subcutaneous Panniculitis-like T-Cell Lymphoma--Review.
10.19746/j.cnki.issn.1009-2137.2021.01.050
- Author:
Li-Hua QIU
1
,
2
;
Chen TIAN
1
,
3
Author Information
1. Department of Hematology, Tianjin Medical University Cancer Institute & Hospital
2. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
3. National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China,E-mail: tianchen@tjmuch.com.
- Publication Type:Review
- MeSH:
Aged;
Humans;
Lymphoma, T-Cell;
Lymphoma, T-Cell, Cutaneous;
Middle Aged;
Panniculitis;
Skin Neoplasms
- From:
Journal of Experimental Hematology
2021;29(1):297-300
- CountryChina
- Language:Chinese
-
Abstract:
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a very rare cutaneous malignant lymphoma derived from cytotoxic T cells that mainly involves subcutaneous adipose tissue rather than epidermis and dermis. It usually occurs in young and middle-aged population, and the etiology is currently unclear. Clinically, SPTCL is characterized by subcutaneous plaques, nodules, and skin ulcers with swell and ache, mainly presenting in limbs and trunk. SPTCL has been restricted to cases that express α/β phenotype, whereas cases with γ/δ phenotype are categorized to cutaneous γ/δ
